EUVIMEDEUVIMED entdecken
Crossref

Blockade of the Platelet-Driven CXCL7-CXCR1/2 Inflammatory Axis Prevents Murine Cerebral Aneurysm Formation and Rupture

Kamil W Nowicki, Aditya Mittal, Joseph S Hudson, Michael P D'Angelo, Michael M McDowell, Catherine Cao, Rohit Mantena, Abhishek Jauhari, Robert M Friedlander

Translational Stroke Research · 2025

DOI: 10.1007/s12975-024-01304-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, 2025. Verfasst von Kamil W Nowicki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Pittsburgh School of Medicine, 200 Lothrop Street, Suite B-400, Pittsburgh, PA, 15213, USA. kn2675@…. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Receptors, Interleukin-8B, Blood Platelets, Aneurysm, Ruptured. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Brain Aneurysm Foundation, The Pittsburgh Foundation / Copeland Foundation, Humanity in Action.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet aggregation is intimately associated with vascular inflammation and is commonly seen on routine histology studies of cerebral aneurysms. Platelets, when activated, have been shown to augment neutrophil response and the pro-inflammatory cascade. Platelet-neutrophil complexes have been found to aggravate atherosclerosis through a positive feedback loop. We hypothesized that targeting platelet aggregation and downstream inflammation could be used to prevent aneurysm formation and progression. First, we induced cerebral aneurysm formation in a previously described intracranial aneurysm model via carotid artery ligation, hypertension, and stereotactic elastase injection in C57BL/6 mice and analyzed vessels for lesion and thrombus formation. Raybiotech cytokine arrays were used to analyze 96 cytokines in induced murine aneurysms and 120 cytokines in human tissue samples. Cerebral aneurysm formation and inflammatory pathway were then studied in animals treated with IgG2 antibody (control), anti-GpIb antibody (platelet depletion), 1:10 DMSO:PBS (control), clopidogrel, anti-CXCR1/2 small molecule inhibitor, or anti-CXCL7 antibody. Bleeding assays and flow cytometry were used to evaluate platelet function in treated groups. CD31 + platelet aggregates are a common feature in human and mouse cerebral aneurysm specimens. Platelet ablation in mice prevents cerebral aneurysm formation (20% vs 100% in control antibody-treated mice, n = 5 each, p = 0.0476). Mice treated with 1 mg/kg clopidogrel develop significantly less aneurysms than controls (18% vs 73%, n = 11 and 11, respectively, p = 0.03). Semi-quantitative analysis of 96 different cytokines using Raybiotech arrays shows increased protein expression of CXCL7 in murine cerebral aneurysms when compared to controls. Treatment with clopidogrel results in reciprocal decrease in detected CXCL7. Targeting CXCL7-CXCR1/2 axis with 10 mg/kg reparixin (CXCR1/2 antagonist) significantly decreases cerebral aneurysm formation (11% vs 73%, n = 9 and 11, p = 0.0098) while treatment with 10 mg/kg SB225002 tends to decrease aneurysm formation (36% vs 73%, n = 11 vs n = 7, p = 0.11). Lastly, specific antibody blockade against CXCL7 using anti-CXCL7 antibody at 100 ug/mL significantly decreases cerebral aneurysm formation (29% vs 75%, n = 7 vs n = 8, p = 0.046). Platelet inflammation has an important role in cerebral aneurysm formation. Small molecule inhibitors targeting platelet CXCL7-CXCR1/2 inflammatory axis could be used to prevent cerebral aneurysm formation or progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial AneurysmReceptors, Interleukin-8BBlood PlateletsAneurysm, RupturedAnimalsMice, Inbred C57BLMiceDisease Models, AnimalHumansMalePlatelet Aggregation InhibitorsClopidogrelInflammationPlatelet AggregationReceptors, CXCR

Stichwörter der Autor:innen

AneurysmCXCL7CXCR1/2CerebralInflammationMurinePlatelet

Substanzen

Receptors, Interleukin-8BCxcr2 protein, mouseCmkor1 protein, mousePlatelet Aggregation InhibitorsClopidogrelReceptors, CXCR

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of Pittsburgh School of Medicine, 200 Lothrop Street, Suite B-400, Pittsburgh, PA, 15213, USA. kn2675@cumc.columbia.edu.
  • Department of Neurological Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA. kn2675@cumc.columbia.edu.
  • Department of Neurological Surgery, University of Pittsburgh School of Medicine, 200 Lothrop Street, Suite B-400, Pittsburgh, PA, 15213, USA.
  • Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Förderung

  • Brain Aneurysm Foundation
  • The Pittsburgh Foundation / Copeland Foundation
  • Humanity in Action

Zitieren

APA

Nowicki, K. W., Mittal, A., Hudson, J. S., D'Angelo, M. P., McDowell, M. M., Cao, C., Mantena, R., Jauhari, A., & Friedlander, R. M. (2025). Blockade of the Platelet-Driven CXCL7-CXCR1/2 Inflammatory Axis Prevents Murine Cerebral Aneurysm Formation and Rupture. Translational Stroke Research. https://doi.org/10.1007/s12975-024-01304-2

Vancouver

Nowicki KW, Mittal A, Hudson JS, D'Angelo MP, McDowell MM, Cao C, et al. Blockade of the Platelet-Driven CXCL7-CXCR1/2 Inflammatory Axis Prevents Murine Cerebral Aneurysm Formation and Rupture. Translational Stroke Research. 2025. doi:10.1007/s12975-024-01304-2

BibTeX
@article{Nowicki2025,
  author = {Nowicki, Kamil W and Mittal, Aditya and Hudson, Joseph S and D'Angelo, Michael P and McDowell, Michael M and Cao, Catherine and Mantena, Rohit and Jauhari, Abhishek and Friedlander, Robert M},
  title = {Blockade of the Platelet-Driven CXCL7-CXCR1/2 Inflammatory Axis Prevents Murine Cerebral Aneurysm Formation and Rupture},
  journal = {Translational Stroke Research},
  year = {2025},
  doi = {10.1007/s12975-024-01304-2}
}
Kostenlos starten →